Takashi Mizuma

1.0k total citations
61 papers, 864 citations indexed

About

Takashi Mizuma is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Takashi Mizuma has authored 61 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Molecular Biology and 18 papers in Pharmacology. Recurrent topics in Takashi Mizuma's work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Takashi Mizuma is often cited by papers focused on Drug Transport and Resistance Mechanisms (23 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Takashi Mizuma collaborates with scholars based in Japan, Italy and United States. Takashi Mizuma's co-authors include Shoji Awazu, Masahiro Hayashi, Kunihiro Ohta, Toshiharu Horie, Emil T. Lin, Leslie Z. Benet, Hildegard Spahn‐Langguth, E. Mutschler, Minoru Machida and Hiroshi Araya and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, International Journal of Pharmaceutics and Biochemical Pharmacology.

In The Last Decade

Takashi Mizuma

61 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Mizuma Japan 14 351 294 282 107 80 61 864
Thomas N. Thompson United States 14 454 1.3× 252 0.9× 334 1.2× 70 0.7× 50 0.6× 39 1.3k
Viviane Meunier France 8 308 0.9× 396 1.3× 507 1.8× 115 1.1× 114 1.4× 9 1.1k
L. Vereczkey Hungary 21 341 1.0× 358 1.2× 547 1.9× 182 1.7× 69 0.9× 89 1.4k
Masahiro Iwaki Japan 18 271 0.8× 304 1.0× 268 1.0× 139 1.3× 156 1.9× 71 924
Zuyu Guo United States 18 635 1.8× 212 0.7× 507 1.8× 75 0.7× 56 0.7× 24 1.2k
Martine Bourrié France 10 221 0.6× 337 1.1× 514 1.8× 96 0.9× 90 1.1× 13 890
Nancy Eddy Hopkins United States 17 306 0.9× 197 0.7× 434 1.5× 50 0.5× 25 0.3× 25 905
Lijun Wu China 15 367 1.0× 174 0.6× 344 1.2× 160 1.5× 44 0.6× 39 961
Jinping Hu China 19 484 1.4× 205 0.7× 258 0.9× 101 0.9× 51 0.6× 76 1.0k
A. B. Renwick United Kingdom 24 347 1.0× 341 1.2× 857 3.0× 137 1.3× 50 0.6× 34 1.4k

Countries citing papers authored by Takashi Mizuma

Since Specialization
Citations

This map shows the geographic impact of Takashi Mizuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Mizuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Mizuma more than expected).

Fields of papers citing papers by Takashi Mizuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Mizuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Mizuma. The network helps show where Takashi Mizuma may publish in the future.

Co-authorship network of co-authors of Takashi Mizuma

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Mizuma. A scholar is included among the top collaborators of Takashi Mizuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Mizuma. Takashi Mizuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohta, Shin, et al.. (2013). A Toxicity Risk Index, An Index for Warning Idiosyncratic Drug Toxicity. Journal of Pharmaceutical Sciences. 102(9). 3447–3450. 2 indexed citations
2.
Mizuma, Takashi. (2009). Impact of intestinal metabolism on drug development. Folia Pharmacologica Japonica. 134(3). 142–145. 1 indexed citations
3.
Mizuma, Takashi. (2006). Drug delivery system based on transport characteristics of biological membranes Drug delivery system utilizing sugar transporter. Drug Delivery System. 21(2). 126–133. 2 indexed citations
4.
Mizuma, Takashi, et al.. (2005). Kinetic characterization of glycosidase activity from disaccharide conjugate to monosaccharide conjugate in Caco-2 cells. Journal of Pharmacy and Pharmacology. 57(5). 661–664. 6 indexed citations
5.
6.
Mizuma, Takashi & Shoji Awazu. (2004). Dietary polyphenols (−)-epicatechin and chrysin inhibit intestinal glucuronidation metabolism to increase drug absorption. Journal of Pharmaceutical Sciences. 93(9). 2407–2410. 12 indexed citations
7.
Mizuma, Takashi, et al.. (2000). Intestinal transport and metabolism of glucose-conjugated kyotorphin and cyclic kyotorphin: metabolic degradation is crucial to intestinal absorption of peptide drugs. Biochimica et Biophysica Acta (BBA) - General Subjects. 1475(1). 90–98. 18 indexed citations
8.
Mizuma, Takashi, et al.. (1999). Intestinal Absorption of Acyclovir β-Glucoside: Comparative Study with Acyclovir, Guanosine, and Kinetin β-Glucoside. Pharmaceutical Research. 16(1). 69–73. 11 indexed citations
9.
10.
Ohnishi, Toshimasa, et al.. (1998). Transport mechanisms of a glycoside, p-nitrophenyl-β-d-glucopyranoside, across rat small intestinal brush-border membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1370(2). 192–198. 5 indexed citations
11.
Mizuma, Takashi, Leslie Z. Benet, & Emil T. Lin. (1998). High-performance liquid chromatographic determination and identification of acyl migration and photodegradation products of furosemide 1-O-acyl glucuronide. Journal of Chromatography B Biomedical Sciences and Applications. 718(1). 153–162. 17 indexed citations
12.
Mizuma, Takashi, et al.. (1997). Intestinal transport and metabolism of analgesic dipeptide, kyotorphin: rate-limiting factor in intestinal absorption of peptide as drug. Biochimica et Biophysica Acta (BBA) - General Subjects. 1335(1-2). 111–119. 10 indexed citations
13.
Mizuma, Takashi, Kunihiro Ohta, Masahiro Hayashi, & Shoji Awazu. (1993). Comparative study of active absorption by the intestine and disposition of anomers of sugar-conjugated compounds. Biochemical Pharmacology. 45(7). 1520–1523. 33 indexed citations
14.
Hayashi, Masahiro, et al.. (1992). ACTION MECHANISM OF PERMEATION ENHANCERS IN PARACELLULAR PATHWAY. Journal of Pharmacobio-Dynamics. 15(2). 1 indexed citations
15.
Nakamura, Junko, Takashi Mizuma, Masahiro Hayashi, & Shoji Awazu. (1990). Correlation of phenol sulphotransferase activities in the liver and platelets of rat. Journal of Pharmacy and Pharmacology. 42(3). 207–208. 1 indexed citations
16.
Horie, Toshiharu, et al.. (1987). Fluorescence Energy Transfer Study of the Relationship Between the Lone Tryptophan Residue and Drug Binding Sites in Human Serum Albumin. Journal of Pharmaceutical Sciences. 76(5). 387–392. 80 indexed citations
17.
Mizuma, Takashi, Toshiharu Horie, Masahiro Hayashi, & Shoji Awazu. (1986). ALBUMIN-MEDIATED UPTAKE MECHANISM OF DRUG BY ISOLATED HEPATOCYTES. Journal of Pharmacobio-Dynamics. 9(6). 3 indexed citations
18.
Mizuma, Takashi, Masahiro Hayashi, & Shoji Awazu. (1985). Factors influencing drug sulfate and glucoronic acid conjugation rates in isolated rat hepatocytes: significance of preincubation time. Biochemical Pharmacology. 34(14). 2573–2575. 12 indexed citations
19.
Kai, Yasushi, Takashi Mizuma, Noritake Yasuoka, & Nobutami Kasai. (1983). The Crystal Structure of 2,11,20-Trithia[3.3.3](1,2,4)(1,3,5)cyclophane and Molecular Structures of Unsymmertically Tris-bridged[2.2.2](1,2,4)(1,3,5) and [2.2.2](1,2,4)(1,2,5)Cyclophanes, Estimated by Molecular Conformational Analysis. Bulletin of the Chemical Society of Japan. 56(10). 3037–3041. 1 indexed citations
20.
Mizuma, Takashi, Masahiro Hayashi, & Shoji Awazu. (1983). p-Nitrophenol sulfation in rat liver cytosol: Multiple forms and substrate inhibition of aryl sulfotransferase.. Journal of Pharmacobio-Dynamics. 6(11). 851–858. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas N. Thompson Breakdown of academic impact, for papers by Viviane Meunier Breakdown of academic impact, for papers by L. Vereczkey Breakdown of academic impact, for papers by Masahiro Iwaki Breakdown of academic impact, for papers by Zuyu Guo Breakdown of academic impact, for papers by Martine Bourrié Breakdown of academic impact, for papers by Nancy Eddy Hopkins Breakdown of academic impact, for papers by Lijun Wu Breakdown of academic impact, for papers by Jinping Hu Breakdown of academic impact, for papers by A. B. Renwick
Rankless by CCL
2026